Macquarie Group LTD Enanta Pharmaceuticals Inc Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $10,623 - $15,679	-220 Reduced 55.28%	178 $21,000
Q1 2021 May 14, 2021	SELL	$41.69 - $54.95 $4,377 - $5,769	-105 Reduced 20.87%	398 $20,000
Q2 2020 Aug 11, 2020	BUY	$46.37 - $57.58 $23,324 - $28,962	503 New	503 $25,000
Q1 2018 May 11, 2018	SELL	$57.91 - $92.15 $156,357 - $248,805	-2,700 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$45.65 - $59.37 $95,865 - $124,677	2,100 Added 350.0%	2,700 $158,000
Q3 2017 Nov 08, 2017	BUY	$37.91 - $46.8 $22,745 - $28,080	600	600 $28,000

107

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $102M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.